New Blood Pressure Medication Recall Due To 'Life Threatening' Mixup

New Blood Pressure Medication Recall Due To 'Life Threatening' Mixup

New Blood Pressure Medication Recall Due To 'Life Threatening' Mixup

The FDA says there could be a labeling mix-up, after finding a bottle filled with different medication inside.

Accord Healthcare Inc.is voluntarily recalling One lot (Lot PW05264 - 46632 Bottles, NDC 16729-182-01) of Hydrochlorothiazide Tablets USP, 12.5 mg, to the consumer level.

The medication found in the bottle was created to reduce a hormone that affects blood pressure. People who take spironolactone by mistake could experience high levels of potassium as a result.

NASA details fix of small ISS leak caused by micrometeoroid
Both NASA and the European Space Agency (ESA) argued the breach was not risky enough to wake the astronauts from their slumber. The European Space Agency reported crew members are in no danger, as there are weeks of air left in the ISS reserves.

Accord officials said they have not had reports of adverse incidents relating to this recall, according to the FDA release.

The FDA says the correct tablets should be light orange and round with an "H" on one side and a number "1" on the other side.

For some, the medication mixup could be "life-threatening", according to the FDA's recall notice.

The Houston Rockets have traded Ryan Anderson to the Suns
Anderson is owed $41 million over the final two years of his contract compared to two years and $30 million for Knight. Melton was a second-round pick out of USC this year who had some good moments in Summer League play.

Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. Consumers are urged to report any drugs that do not match that description, or check with their pharmacist. Drugs containing valsartan experienced a recall over concerns over the drug being tainted with a compound that potentially increases cancer risks. Adverse events may be reported to FDA through its MedWatch program. The affected drugs in that recall may have been contaminated with N-nitrosodimethylamine or NDMA, which the U.S. Environmental Protection Agency considers a possible carcinogen.

If you're taking any kind of prescription medication for your high blood pressure, it's worth double-checking your medicine cabinet.

Coca-Cola to buy UK’s Costa Coffee chain for $5.1 billion
The sale will yield a "substantial premium" to the value that would have been created through a spin-off, Whitbread said. Whitbread acquired Costa in 1995 for £19m from founders Sergio and Bruno Costa when it had only 39 shops.

Related news